Table 2.
Study | Study type | Design | Number of MSCs |
Outcomes |
---|---|---|---|---|
Gulotta et al.58 |
In vivo rat model |
Supraspinatus repair with or without allogenic BM- MSCs |
106 /animal |
No significant difference in strength of repair, cross-sectional area, stress to failure, or stiffness. Non-significant but consistently higher amounts of fibrocartilage |
Gulotta et al.60 |
In vivo rat model |
Supraspinatus repair with allogenic BM-MSCs either transduced with MT1-MMP or not. No non-BM-MSC controls |
106 /animal |
Significant increases in load to failure, stiffness, and levels of fibrocartilage |
Gulotta et al. 61 |
In vivo rat model |
Supraspinatus repair with allogenic BM-MSCs either transduced with BMP-13 or not. No non- BM-MSC controls |
106 /animal |
No significant increase in fibrocartilage, improvements in collagen organization, strength of repair, cross-sectional area, stress to failure, or stiffness |
Gulotta et al. 62 |
In vivo rat model |
Supraspinatus repair with allogenic BM-MSCs either transduced with scleraxis or not. No non- BM-MSC controls |
106 /animal |
Significant increases in fibrocartilage, load to failure, stress to failure, and stiffness |
Hernigou et al.63 |
Prospective case- controlled cohort study |
All-sized RC tears repaired with or without autogenous BM-MSCs (harvested from anterior iliac spine) |
51,000/ 12 mL |
Significant improvement in ultrasound- and MRI-assessed healing at 6 months and 10 years. Positive correlation between concentration of BM-MSCs transferred and tendon healing at 10 years |
Kida et al.66 |
In vivo rat model |
Supraspinatus repair with or without drilling of the greater tuberosity to release GFP BM-MSCs |
n/a | Significantly higher levels of GFP BM- MSCs at repair site in drilled rats, as well as higher load to failure |
Jo et al.67 | Prospective case- controlled cohort study |
All-sized RC tears repaired with or without channeling of the greater tuberosity |
n/a | Significantly more BM-MSCs found in channeled patients, as confirmed by flow cytometry. Significant improvement in re- tear rate but no other clinical outcomes |
Taniguchi et al.68 |
Prospective case- controlled cohort study |
All-sized RC tears repaired with or without BMS |
n/a | Significantly lower re-tear in stimulated group, especially among patients with larger tears. No testing was performed to confirm the presence of BM-MSCs. |